In the world of advanced therapeutics, time is often the most precious commodity. Every day lost to technical setbacks or regulatory complexity can translate into delayed treatments for patients. For ...

Two-day Cell Therapy Conclave at KMC Manipal on October 30 to explore advances in regenerative medicine and cellular ...

In this interview, Richard Chung, Product Manager at Wyatt Technology, discusses the development of the DynaPro Plate Reader 4, a next-generation system designed to bring powerful light scattering ...

Return on Equity (ROE): Arcutis Biotherapeutics's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -11.28%, the company may face hurdles ...

Bud Halim is a senior marketing analyst at Wyatt Technology with a PhD in physical chemistry from UCLA. He began as an adjunct professor teaching biochemistry and chemistry, while contributing as ...